Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Clinical trial NCT00515827 · COMPLETED
Trial details
- NCT number
- NCT00515827
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.